Spannagl M - Search Results

1

A model for the harmonisation of test results of different quantitative D-dimer methods.

Meijer P, Haverkate F, Kluft C, de Moerloose P, Verbruggen B, Spannagl M. Meijer P, et al. Among authors: spannagl m. Thromb Haemost. 2006 Mar;95(3):567-72. doi: 10.1160/TH05-01-0042. Thromb Haemost. 2006. PMID: 16525589 Free article.

2

The performance of quantitative D-dimer assays in laboratory routine.

Spannagl M, Haverkate F, Reinauer H, Meijer P. Spannagl M, et al. Blood Coagul Fibrinolysis. 2005 Sep;16(6):439-43. doi: 10.1097/01.mbc.0000179912.80656.2b. Blood Coagul Fibrinolysis. 2005. PMID: 16093735

3

Protection of single-chain urokinase-type plasminogen activator (scu-PA) in aprotinin treated cardiac surgical patients undergoing cardiopulmonary bypass.

Spannagl M, Dooijewaard G, Dietrich W, Kluft C. Spannagl M, et al. Thromb Haemost. 1995 May;73(5):825-8. Thromb Haemost. 1995. PMID: 7482410 Clinical Trial.

4

Importance of levonorgestrel dose in oral contraceptives for effects on coagulation.

Kluft C, de Maat MP, Heinemann LA, Spannagl M, Schramm W. Kluft C, et al. Among authors: spannagl m. Lancet. 1999 Sep 4;354(9181):832-3. doi: 10.1016/s0140-6736(99)80017-8. Lancet. 1999. PMID: 10485729

5

The association between extrinsic activated protein C resistance and venous thromboembolism in women.

Heinemann LA, Kluft C, Spannagl M, de Maat MP. Heinemann LA, et al. Among authors: spannagl m. Contraception. 2002 Nov;66(5):297-304. doi: 10.1016/s0010-7824(02)00388-8. Contraception. 2002. PMID: 12443958

6

D-dimer as marker for microcirculatory failure: correlation with LOD and APACHE II scores.

Angstwurm MW, Reininger AJ, Spannagl M. Angstwurm MW, et al. Among authors: spannagl m. Thromb Res. 2004;113(6):353-9. doi: 10.1016/j.thromres.2004.03.013. Thromb Res. 2004. PMID: 15226089 Clinical Trial.

7

Normalized activated protein C ratio itself not associated with increased risk of venous thromboembolism.

Heinemann LA, Assmann A, Spannagl M, Schramm W, Dick A, Kluft C, de Maat MP. Heinemann LA, et al. Among authors: spannagl m. Contraception. 1998 Nov;58(5):321-2. doi: 10.1016/s0010-7824(98)00111-5. Contraception. 1998. PMID: 9883389

8

No influence of heparin plasma and other (pre)analytic variables on D-dimer determinations.

Schutgens RE, Haas FJ, Ruven HJ, Spannagl M, Horn K, Biesma DH. Schutgens RE, et al. Among authors: spannagl m. Clin Chem. 2002 Sep;48(9):1611-3. Clin Chem. 2002. PMID: 12194950 No abstract available.

9

A new immunoassay for soluble fibrin enables a more sensitive detection of the activation state of blood coagulation in vivo.

Lill H, Spannagl M, Trauner A, Schramm W, Schuller D, Ofenloch-Haehnle B, Draeger B, Naser W, Dessauer A. Lill H, et al. Among authors: spannagl m. Blood Coagul Fibrinolysis. 1993 Feb;4(1):97-102. Blood Coagul Fibrinolysis. 1993. PMID: 8457660

10

The value of quantitative fibrin monomer determination in the early diagnosis of postoperative deep vein thrombosis.

Vogel G, Dempfle CE, Spannagl M, Leskopf W. Vogel G, et al. Among authors: spannagl m. Thromb Res. 1996 Jan 15;81(2):241-51. doi: 10.1016/0049-3848(95)00241-3. Thromb Res. 1996. PMID: 8822139

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

325 results

Search Page

Filters